Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.
Verified emails & LinkedIn for founders across this portfolio.
Asgard Therapeutics is a Biotechnology Company.
Octave provides mental health care that's both accessible to people and sustainable for providers.
Revagenix is a biopharmaceutical company discovering and developing therapies to address medical needs.
Nalu Medical is a medical technology company that develops innovative solutions for patients with chronic neuropathic pain.
Hoba Therapeutics is developing a new therapeutic protein for the treatment of neuropathic pain.
Doctor Anywhere is a telehealth company .
Exscientia is a pharmatech company that uses an end-to-end AI platform to design and discover new drugs.
Arcellx develops engineered cell-based immunotherapies for the treatment of cancer and other serious diseases.
NMD Pharma is a small molecule drug discovery company that develops novel treatments of neuromuscular disorders.
Minervax is a biotechnology company developing a novel vaccine against Group B Streptococcus.
Acesion Pharma is a developer of medical drugs designed for the treatment of atrial fibrillation.
Pioneering the market introduction of powerful, autonomous, safe and eco-friendly water and air treatment solutions.
Inozyme is a biopharmaceutical company developing therapeutics for rare diseases, with a focus on bone health.
CorWave is a medical device company developing innovative heart pumps.
Morphic Therapeutic is a biotechnology company that develops oral integrin therapies to treat serious chronic diseases.
Clever Care Health Plan is a healthcare company that offers medicare advantage health plans to its members.
Aquafortus is a non-thermal recovery and crystallization technology platform.
Evosep develops new solutions to make clinical proteomics 100 times more robust and 10 times faster.
iECURE is a mutation-agnostic in vivo gene editing company striving to cure devastating diseases with high unmet needs.
Kate Farms offers plant-based shakes and formulas for tube-fed adults and children.
Swift Health Systems is a stealth stage start-up medical device company, developing INBRACE.
Inspirna is a biotechnology company developing drugs for the treatment of cancer.
Biosyntia is a biotech startup within synthetic biology and metabolic engineering.
Invetx is a veterinary therapeutics company that develops protein-based therapeutics for the treatment of various animal diseases.
Novo Holdings has invested in 216 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.
Novo Holdings's top investment sectors include Biotechnology, Health Care, Pharmaceutical, Medical, Therapeutics. The firm invests across 32 different industry categories.
Among tracked funding rounds, Morphic Therapeutic received $276.0M in a Post-IPO Equity round. Novo Holdings's total known invested capital is $18.6B.
Novo Holdings's average investment size is $86.1M across its portfolio of 216 companies.
Recent Novo Holdings portfolio additions include Asgard Therapeutics, Octave, Revagenix, Nalu Medical, Hoba Therapeutics. These companies were founded in 2020 or later.